Senior Leadership

$138,652P30FY2014CANIH

Ohio State University, Columbus OH

Investigators

Linked publications & trials

Paper 39712992 Paper 39659782 Paper 39644403 Paper 39615117 Paper 39605359 Paper 39554133 Paper 39545924 Paper 39535537 Paper 39521617 Paper 39511408 Paper 39506780 Paper 39451779 Paper 39445831 Paper 39405639 Paper 39401257 Paper 39400395 Paper 39397763 Paper 39369270 Paper 39367245 Paper 39361354 Paper 39343324 Paper 39330666 Paper 39288704 Paper 39288505 Paper 39283025 Paper 39258462 Paper 39223839 Paper 39221867 Paper 39210964 Paper 39197539 Paper 39188992 Paper 39174449 Paper 39164287 Paper 39155749 Paper 39149287 Paper 39125973 Paper 39123364 Paper 39110445 Paper 39070662 Paper 39044819 Paper 39039092 Paper 39015091 Paper 38986733 Paper 38980909 Paper 38976738 Paper 38971316 Paper 38969946 Paper 38953668 Paper 38948867 Paper 38947012 Paper 38946472 Paper 38937454 Paper 38926849 Paper 38914647 Paper 38911592 Paper 38909035 Paper 38904265 Paper 38902472 Paper 38902313 Paper 38900577 Paper 38899881 Paper 38895849 Paper 38890323 Paper 38872045 Paper 38871731 Paper 38866818 Paper 38854924 Paper 38851853 Paper 38836758 Paper 38826406 Paper 38821952 Paper 38820600 Paper 38820378 Paper 38814980 Paper 38809718 Paper 38809542 Paper 38806673 Paper 38800982 Paper 38797949 Paper 38791996 Paper 38787791 Paper 38781455 Paper 38771951 Paper 38769532 Paper 38760681 Paper 38744252 Paper 38729110 Paper 38725994 Paper 38723251 Paper 38716828 Paper 38709075 Paper 38702786 Paper 38696205 Paper 38690566 Paper 38688277 Paper 38678524 Paper 38663398 Paper 38662438 Paper 38659935 Paper 38657717

Abstract

In 2003 the OSUGCC Senior Leadership Team consisted of Michael A. Caligiuri, M.D. as Director, David E. Schuller, M.D. as Deputy Director, Michael Lairmore, D.V.M, Ph.D. as Associate Director for Basic Research, William E. Carson, M.D. as Associate Director for Clinical Research, Electra Paskett, Ph.D. as Associate Director for Population Sciences and Mr. Jeff Walker as Associate Director for Administration. At that time, the NCI review committee rated Senior Leadership as outstanding and noted: The outstanding Senior Leadership group has demonstrated the ability to address recommendations from the last review, recruited well-qualified investigators from outside of OSU, provided a successful environment for collaborative research, reorganized the programs, added appropriate new resources and is providing support for investigators as they prepare and submit proposals for peer-reviewed funding. Overall, this is viewed as a very strong Leadership team with appropriate vision for the future of cancer research at the OSUCCC. There were no shortcomings noted.

View original record on NIH RePORTER →